DJ ADRs Close Lower; RedHill Biopharma Rises
International stocks trading in New York closed lower on Monday.
The S&P/BNY Mellon index of American depositary receipts fell 1.1% to 157.34. The European index declined 0.3% to 140.16. The Asian index fell 2.2% to 209.35. The Latin American index declined 1.7% to 186.46. And the emerging-markets index fell 2.1% to 344.21.
RedHill Biopharma Ltd. was among the companies whose ADRs traded actively.
A group of oil producers plans to lift its collective output by 400,000 barrels a day in monthly installments, part of a previously agreed plan to return output to pre-Covid-19 levels. OPEC+, which includes members of the Organization of the Petroleum Exporting Countries and others led by Russia, decided against opening the taps more widely, driving U.S. crude prices to their highest levels since 2014. BP PLC rose 1.5% to $28.01; Eni Spa roes 1% to $27.11; Royal Dutch Shell PLC's Class B ADRs rose 1% to $45.38; and TotalEnergies SE improved 1.3% to $48.67.
RedHill Biopharma Ltd.'s ADRs closed 12% higher at $4.88 after the company said it had new data from a Phase 2/3 clinical study evaluating its experimental oral antiviral opaganib in severely ill, hospitalized Covid-19 patients, MarketWatch reported. RedHill said the treatment candidate reduced mortality by 62% when evaluating 251 of the 475 patients enrolled in the study.
(END) Dow Jones Newswires
October 04, 2021 18:09 ET (22:09 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.